Literature DB >> 2690911

5-Fluorouracil and folinic acid: interesting biochemistry or effective treatment?

D J Kerr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2690911      PMCID： PMC2247260          DOI： 10.1038/bjc.1989.370

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  5 in total

1.  Cisplatin, fluorouracil with leucovorin calcium enhancement, and synchronous accelerated radiotherapy in the management of locally advanced head and neck cancer: a phase II study.

Authors:  T G Wendt; R C Hartenstein; T P Wustrow; J Lissner
Journal:  J Clin Oncol       Date:  1989-04       Impact factor: 44.544

2.  Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil.

Authors:  R M Evans; J D Laskin; M T Hakala
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

3.  The effect of derivatives of folic acid on the fluorodeoxyuridylate-thymidylate synthetase covalent complex in human colon xenografts.

Authors:  J A Houghton; C Schmidt; P J Houghton
Journal:  Eur J Cancer Clin Oncol       Date:  1982-04

4.  Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.

Authors:  D Machover; E Goldschmidt; P Chollet; G Metzger; J Zittoun; J Marquet; J M Vandenbulcke; J L Misset; L Schwarzenberg; J B Fourtillan
Journal:  J Clin Oncol       Date:  1986-05       Impact factor: 44.544

5.  A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.

Authors:  J J Lokich; J D Ahlgren; J J Gullo; J A Philips; J G Fryer
Journal:  J Clin Oncol       Date:  1989-04       Impact factor: 44.544
  5 in total
  10 in total

1.  Disposition of 5-formyl- and 5-methyltetrahydrofolic acid in serum after i.v. bolus of calcium folinate: pharmacokinetic drug interaction with preadministered interferon-alpha-2b.

Authors:  M J Czejka; J Schüller; C Weiss; S Bandak; B Meyer; D Simon
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Oct-Dec       Impact factor: 2.441

Review 2.  Clinical pharmacokinetic advantages of new drug delivery methods for the treatment of liver tumours.

Authors:  J H Anderson; H W Warren; C S McArdle
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

3.  The cost of folinic acid.

Authors:  J B Healy
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

4.  Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines.

Authors:  M C Etienne; S Bernard; J L Fischel; P Formento; J Gioanni; J Santini; F Demard; M Schneider; G Milano
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

5.  Paradoxical effects of 5-FU/folinic acid on lymphokine-activated killer (LAK) cell induction in patients with colorectal cancer.

Authors:  H Onodera; S S Somers; P J Guillou
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

6.  A phase I study of regional 5-fluorouracil and systemic folinic acid for patients with colorectal liver metastases.

Authors:  J H Anderson; D J Kerr; T G Cooke; C S McArdle
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

7.  The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour.

Authors:  D M Hemingway; T G Cooke; D Chang; S J Grime; S A Jenkins
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

8.  Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastases.

Authors:  J A Goldberg; J A Thomson; M S Bradnam; J Fenner; R G Bessent; J H McKillop; D J Kerr; C S McArdle
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

9.  A pharmacokinetic comparison of intravenous versus intra-arterial folinic acid.

Authors:  J H Anderson; D J Kerr; A Setanoians; T G Cooke; C S McArdle
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

10.  A phase II study of regional 5-fluorouracil infusion with intravenous folinic acid for colorectal liver metastases.

Authors:  H W Warren; J H Anderson; P O'Gorman; E Kane; D J Kerr; T G Cooke; C S McArdle
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.